During the last session, Syndax Pharmaceuticals Inc (NASDAQ:SNDX)’s traded shares were 1.13 million, with the beta value of the company hitting 0.74. At the end
In the last trading session, 3.9 million shares of the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) were traded, and its beta was 0.78. Most recently the company’s
Syndax Pharmaceuticals Inc (NASDAQ:SNDX)’s traded shares stood at 2.83 million during the last session, with the company’s beta value hitting 0.77. At the close of
In the last trading session, 2.87 million Syndax Pharmaceuticals Inc (NASDAQ:SNDX) shares changed hands as the company’s beta touched 0.67. With the company’s per share
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) has a beta value of 0.78 and has seen 2.13 million shares traded in the last trading session. The company, currently
During the last session, Syndax Pharmaceuticals Inc (NASDAQ:SNDX)’s traded shares were 3.58 million, with the beta value of the company hitting 0.86. At the end
In today’s recent session, 1.91 million shares of the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) have been traded, and its beta is 0.86. Most recently the company’s
In the last trading session, 1.66 million Syndax Pharmaceuticals Inc (NASDAQ:SNDX) shares changed hands as the company’s beta touched 0.82. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne